A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN CAT-ALLERGIC PATIENTS WITH ALLERGIC RHINITIS WHO LIVE WITH A CAT TO ASSESS THE EFFICACY AND SAFETY OF ANTI-FEL D 1 ANTIBODIES DURING NATURAL CAT EXPOSURE IN THE HOME
- Registry ID
- R1908-1909-ALG-2102
- Source registry
- HEALTH_CANADA
- Status
- Closed
- Study type
- INTERVENTIONAL
- Sponsor
- REGENERON PHARMACEUTICALS INC
- Start date
- 2021-11-30
- Completion date
- 2022-10-11
- Last update
- 2021-08-27
Conditions
Related clinical trials
- A PHASE 2, RENDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE SAFETY AND EFFICACY IN REDUCING NASAL ALLERGEN CHALLENGE PROVOKED SYMPTOMS OF TREATMENT WITH DM-101PX IN ADULTS WITH BIRCH POLLEN ALLERGIC RHINITIS OR RHINOCONJUNCTIVITIS
- TEZEPELUMAB IN THE TREATMENT OF CO-MORBID ALLERGIC RHINITIS AND ALLERGIC
ASTHMA STUDY (TEZARS) - AN OPEN-LABEL EXPLORATORY MECHANISTIC PILOT
STUDY TO EVALUATE TEZEPELUMAB EFFICACY IN ASTHMA AND ALLERGIC RHINITIS
- A PROSPECTIVE, CONTROLLED, DOUBLE BLIND, MULTI-CENTER, RANDOMIZED, 3 ARM, PHASE 1B/2A STUDY TO ASSESS THE SAFETY, TOLERABILITY, AND PRELIMINARY EFFICACY OF B244 DELIVERED AS AN INTRANASAL SPRAY IN HEALTHY VOLUNTEERS AND SUBJECTS WITH SEASONAL ALLERGIC RHINITIS
- "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF STG320 SUBLINGUAL TABLETS OF HOUSE DUST MITE (HDM) ALLERGEN EXTRACTS IN ADULTS AND ADOLESCENTS WITH HDM-ASSOCIATED ALLERGIC RHINITIS."
View on source registry